Background
Evidence-based review (JCO) by Galloway and Ridge (Fox Chase). Squamous cell carcinoma of unknown primary (SCCUP) of the head and neck: diagnostic evaluation, staging, treatment rationale, and outcomes across neck dissection alone, RT alone, and combined modality.
Interventions and follow up
Design: Narrative review of SCCUP management (workup, RT volumes, chemoradiation)
Primary endpoint: Synthesis of best-practice recommendations
mFollow up: Not applicable
Primary endpoint: Synthesis of best-practice recommendations
mFollow up: Not applicable
Results
Most common occult primary sites: tonsil and base of tongue (increasingly HPV-associated)
Local control: low recurrence rates across all approaches (neck dissection alone, comprehensive neck dissection + CRT, primary chemoradiation)
Controversies: elective treatment of contralateral neck and/or potential mucosal primary site remains debated
Treatment selection: efficacy similar across approaches; toxicity profile is the key differentiator
Local control: low recurrence rates across all approaches (neck dissection alone, comprehensive neck dissection + CRT, primary chemoradiation)
Controversies: elective treatment of contralateral neck and/or potential mucosal primary site remains debated
Treatment selection: efficacy similar across approaches; toxicity profile is the key differentiator
Adverse events
Comprehensive bilateral mucosal + bilateral neck RT: substantial xerostomia, dysphagia, aspiration risk
Limited field: lower toxicity but potential marginal recurrence if mucosal primary missed
Neck dissection morbidity: lymphedema, shoulder dysfunction (radical dissection)
Limited field: lower toxicity but potential marginal recurrence if mucosal primary missed
Neck dissection morbidity: lymphedema, shoulder dysfunction (radical dissection)
Conclusions
SCCUP is increasingly an HPV-related disease with an occult oropharyngeal primary. Modern multimodality treatment with comprehensive staging (TORS/bilateral tonsillectomy) achieves excellent locoregional control; the key question is minimizing treatment-related toxicity (field reduction in HPV+ disease) while maintaining efficacy.
Key Limitations
Narrative review, not a comparative trial; no head-to-head randomized data across modalities; recommendations rely on retrospective series; practice has evolved since 2015 with wider TORS and de-escalation.
Clinical Context
Reference review for SCCUP workup and management. Aligns with ASCO/ESMO head and neck practice favoring comprehensive staging to identify occult primary and field-limited definitive RT/CRT for HPV-associated disease; treatment intent is curative locoregional control.